Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

203 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MRI characteristics of MOG-Ab associated disease in adults: An update.
Shor N, Deschamps R, Cobo Calvo A, Maillart E, Zephir H, Ciron J, Papeix C, Durand-Dubief F, Ruet A, Ayrignac X, Cohen M, Deiva K, Laplaud D, Bourre B, Audoin B, Collongues N, Vukusic S, Cotton F, Marignier R; NOMADMUS study group. Shor N, et al. Among authors: laplaud d. Rev Neurol (Paris). 2021 Jan-Feb;177(1-2):39-50. doi: 10.1016/j.neurol.2020.06.016. Epub 2020 Oct 10. Rev Neurol (Paris). 2021. PMID: 33046261 Review.
The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART'MUS) trial: rationale, objectives and state of advancement.
Vukusic S, Ionescu I, El-Etr M, Schumacher M, Baulieu EE, Cornu C, Confavreux C; Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis Study Group. Vukusic S, et al. J Neurol Sci. 2009 Nov 15;286(1-2):114-8. doi: 10.1016/j.jns.2009.08.056. Epub 2009 Sep 15. J Neurol Sci. 2009. PMID: 19758607 Clinical Trial.
Neuromyelitis optica in France: a multicenter study of 125 patients.
Collongues N, Marignier R, Zéphir H, Papeix C, Blanc F, Ritleng C, Tchikviladzé M, Outteryck O, Vukusic S, Fleury M, Fontaine B, Brassat D, Clanet M, Milh M, Pelletier J, Audoin B, Ruet A, Lebrun-Frenay C, Thouvenot E, Camu W, Debouverie M, Créange A, Moreau T, Labauge P, Castelnovo G, Edan G, Le Page E, Defer G, Barroso B, Heinzlef O, Gout O, Rodriguez D, Wiertlewski S, Laplaud D, Borgel F, Tourniaire P, Grimaud J, Brochet B, Vermersch P, Confavreux C, de Seze J. Collongues N, et al. Among authors: laplaud d. Neurology. 2010 Mar 2;74(9):736-42. doi: 10.1212/WNL.0b013e3181d31e35. Neurology. 2010. PMID: 20194912
[Natural history of adult-onset eIF2B-related disorders: a multicentric survey of 24 cases].
Carra-Dalliere C, Horzinski L, Ayrignac X, Vukusic S, Rodriguez D, Mauguiere F, Peter L, Goizet C, Bouhour F, Denier C, Confavreux C, Obadia M, Blanc F, de Seze J, Sedel F, Guennoc AM, Sartori E, Laplaud D, Antoine JC, Fogli A, Boespflug-Tanguy O, Labauge P. Carra-Dalliere C, et al. Among authors: laplaud d. Rev Neurol (Paris). 2011 Nov;167(11):802-11. doi: 10.1016/j.neurol.2011.03.008. Epub 2011 Jun 14. Rev Neurol (Paris). 2011. PMID: 21676421 French.
Recommendations for useful serum testing with suspected multiple sclerosis.
Ouallet JC, Bodiguel E, Bensa C, Blanc F, Brassat D, Laplaud D, Zephir H, de Seze J, Magy L; Groupe de Re´flexion sur la Scle´rose en Plaques: GRESE. Ouallet JC, et al. Among authors: laplaud d. Rev Neurol (Paris). 2013 Jan;169(1):37-46. doi: 10.1016/j.neurol.2011.09.007. Epub 2012 Feb 8. Rev Neurol (Paris). 2013. PMID: 22325711
Recommendations for a definition of multiple sclerosis in support of early treatment.
Zéphir H, Bodiguel E, Bensa C, Blanc F, Laplaud D, Magy L, Ouallet JC, De Seze J, Brassat D; GRESEP (Groupe de Reflexion sur la Sclerose en Plaques; Multiple Sclerosis Think Tank). Zéphir H, et al. Among authors: laplaud d. Rev Neurol (Paris). 2012 Apr;168(4):328-37. doi: 10.1016/j.neurol.2011.12.008. Epub 2012 Mar 6. Rev Neurol (Paris). 2012. PMID: 22398217
Recommendations for the management of multiple sclerosis relapses.
Laplaud D, Bodiguel E, Bensa C, Blanc F, Brassat D, Magy L, Ouallet JC, Zephir H, De Seze J; GRESEP (Groupe de Reflexion sur la Sclerose en Plaques; Multiple Sclerosis Think Tank). Laplaud D, et al. Rev Neurol (Paris). 2012 May;168(5):425-33. doi: 10.1016/j.neurol.2012.02.006. Epub 2012 May 1. Rev Neurol (Paris). 2012. PMID: 22555010
Recommendations for the detection and therapeutic management of cognitive impairment in multiple sclerosis.
Bensa C, Bodiguel E, Brassat D, Laplaud D, Magy L, Ouallet JC, Zephir H, De Seze J, Blanc F; Multiple Sclerosis Think Tank (Groupe de reflexion sur la sclerose en plaques GRESEP). Bensa C, et al. Among authors: laplaud d. Rev Neurol (Paris). 2012 Nov;168(11):785-94. doi: 10.1016/j.neurol.2012.02.009. Epub 2012 Jun 2. Rev Neurol (Paris). 2012. PMID: 22658753
A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort.
Outteryck O, Ongagna JC, Brochet B, Rumbach L, Lebrun-Frenay C, Debouverie M, Zéphir H, Ouallet JC, Berger E, Cohen M, Pittion S, Laplaud D, Wiertlewski S, Cabre P, Pelletier J, Rico A, Defer G, Derache N, Camu W, Thouvenot E, Moreau T, Fromont A, Tourbah A, Labauge P, Castelnovo G, Clavelou P, Casez O, Hautecoeur P, Papeix C, Lubetzki C, Fontaine B, Couturier N, Bohossian N, Clanet M, Vermersch P, de Sèze J, Brassat D; BIONAT Network,; CFSEP. Outteryck O, et al. Among authors: laplaud d. Eur J Neurol. 2014;21(1):40-8. doi: 10.1111/ene.12204. Epub 2013 Jun 12. Eur J Neurol. 2014. PMID: 23895407 Clinical Trial.
203 results